mercredi 3 juin 2020

Onco Actu du 3 juin 2020


1. BIOLOGIE



Discovery in human acute myeloid leukemia could provide novel pathway to new treatments [EurekAlert!]











4.12 BIOPSIES LIQUIDES



Study Examines Whether Blood Test Can Identify Early Cancers [NCI]










5.1 TRAITEMENTS - PRÉ-CLINIQUE



Tulane scientists find a switch to flip and turn off breast cancer growth and spread [Tulane University]











5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



Researchers Identify Key Immune Checkpoint Protein That Operates Within T Cells [Ohio State University]











5.12.6 IMMUNOTHÉRAPIES - AMM



FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer [Roche]











5.2.6 PHARMA - BIOTECH



Hillhouse leads $160M round for Chinese antibody maker Genor [Fierce Biotech]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma [Sanofi]











EMA Recommends Granting a Marketing Authorisation for Alpelisib [ESMO]











5.4 TRAITEMENTS - ECONOMIE



NIH funded research related to every new cancer drug approved from 2010-2016, totals $64B [EurekAlert!]










5.5.16 ASCO (MÉDECINE DE PRÉCISION)



Evidence for Targeted Treatment Builds in Cancers of Unknown Primary but Randomized Data Pending [Genome Web]











5.9.3 EHA



Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma [Sanofi]











6.15 LUTTE CONTRE LES CANCERS - COVID-19



Impact of COVID-19 infection in blood cancer patients [Queen Mary University of London]